PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemic medicines. PC945 is a novel triazole antifungal...
Alternative Titles
Full title
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_561997543a9b4e2f8952141bb890a0d3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_561997543a9b4e2f8952141bb890a0d3
Other Identifiers
ISSN
2309-608X
E-ISSN
2309-608X
DOI
10.3390/jof6040373
